Clinical trial

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

NCT03965052

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention PRO 179 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Travatan 0.004 % Ophthalmic Solution Normalized identity: travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]View linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-24

PhasePHASE1

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

PRO 179DRUG

Travatan 0.004 % Ophthalmic SolutionDRUG · verified · RxNorm: travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]

Sponsors & collaborators

Laboratorios Sophia S.A de C.V.lead sponsor

Mapped research locations

GuadalajaraJalisco, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03965052 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.